In addition to KIAA1549, many other proteins have been reported as fusion partners to BRAF in glioma, all consisting of an N-terminal dimerization domain from another protein and the C-terminal kinase domain of BRAF, thereby removing the regulatory domain of BRAF without impairing its ability to dimerize (Table 1). The gene discussed is KIAA1549; the disease is glioma.